We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Menlo Therapeutics Inc. operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.
Menlo Therapeutics Inc. has approximately 11-50 employees employees.
Menlo Therapeutics Inc. is based in Redwood City, California, United States.
Yes. Menlo Therapeutics Inc. is a publicly traded company.
You can reach Menlo Therapeutics Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.